Results 91 to 100 of about 3,355 (169)

Human pluripotent stem cell models of Friedreich's ataxia: innovations, considerations, and future perspectives. [PDF]

Stem Cell Res Ther
Nguyen HT, Napierala M, Napierala JS.
europepmc   +1 more source

Robust behavioral assessment of the inducible Friedreich's ataxia mouse does not show improvement with NRF2 induction. [PDF]

Dis Model Mech
Montgomery CB, Salinas L, Cox GP, Adcock LE, Chang T, Figueroa F, Cortopassi G, Dedkova EN.   +7 more
europepmc   +1 more source

Characterizing Population Pharmacokinetics of Vatiquinone in Healthy Volunteers and Patients with Friedreich's Ataxia. [PDF]

Pharmaceuticals (Basel)
Hu Y, Gao L, Lee L, Cherry JJ, Kong R.
europepmc   +1 more source

Friedreich ataxia [PDF]

, 2020
openaire   +1 more source

Early experience on omaveloxolone in adult patients with Friedreich's ataxia: a real-world observational study. [PDF]

J Neurol
Lima SM, Caltagirone M, Messina C, Quartetti U, Rini N, D'Amico F, Brighina F, Di Stefano V.   +7 more
europepmc   +1 more source

Muscle Endurance Training in a Person with Friedreich's Ataxia. [PDF]

Muscles
McGarrell NT, Green ME, McCully KK.
europepmc   +1 more source

Editorial: The mechanistic investigation and emerging therapies for Friedreich's ataxia. [PDF]

Front Pharmacol
Dong Y, Chandran V, Soragni E, Lynch DR.
europepmc   +1 more source

FRIEDREICH'S ATAXIA. [PDF]

The Lancet, 1910
openaire   +1 more source

Exploring mitochondrial biomarkers for Friedreich's ataxia: a multifaceted approach. [PDF]

J Neurol
Stovickova L, Hansikova H, Hanzalova J, Musova Z, Semjonov V, Stovicek P, Hadzic H, Novotna L, Simcik M, Strnad P, Serbina A, Karamazovova S, Schwabova Paulasova J, Vyhnalek M, Krsek P, Zumrova A.   +15 more
europepmc   +1 more source

Safety and efficacy of omaveloxolone v/s placebo for the treatment of Friedreich's ataxia in patients aged more than 16 years: a systematic review. [PDF]

Orphanet J Rare Dis
Umrao A, Pahuja M, Chatterjee NS.
europepmc   +1 more source